New Health Sciences, Inc.
Publicly observedLexington, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Lexington | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | New Health Sciences, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | CC3QRDB7EYX7 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant5 Sept 2025Publicly observed
NIH SBIR/STTR award: Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia
USD 984,232.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant5 Sept 2025Publicly observed
NIH SBIR/STTR award: Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia
USD 1,017,232.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.